Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| 1 |
Cisco
CSCO
|
+$331M |
| 2 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$324M |
| 3 |
Salesforce
CRM
|
+$301M |
| 4 |
Adobe
ADBE
|
+$294M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$216M |
Top Sells
| 1 |
Vodafone
VOD
|
+$422M |
| 2 |
Lloyds Banking Group
LYG
|
+$252M |
| 3 |
Barclays
BCS
|
+$135M |
| 4 |
FIYY
Barclays ETN+ FI Enhanced Global High Yield ETN Series B
FIYY
|
+$72M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$62.6M |
Sector Composition
| 1 | Technology | 17.08% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 12.53% |
| 4 | Consumer Discretionary | 8% |
| 5 | Consumer Staples | 5.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
SAP
SAP
$187B
| $689M | 0.94% |
6,926,072
+170,359
| +3% | +$18.1M |
|
27
HSBC
HSBC
$336B
| $662M | 0.9% |
16,697,158
+188,963
| +1% | +$7.57M |
|
28
Oracle
ORCL
$379B
| $657M | 0.9% |
14,543,137
+420,553
| +3% | +$20.2M |
|
|
NVO
29
Novo Nordisk
NVO
$218B
| $654M | 0.89% |
28,405,870
+811,062
| +3% | +$18M |
|
30
Novartis
NVS
$293B
| $653M | 0.89% |
8,492,349
+205,963
| +2% | +$16M |
|
31
Merck
MRK
$306B
| $644M | 0.88% |
8,830,779
+398,421
| +5% | +$28.1M |
|
|
SI
32
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $633M | 0.86% |
11,368,884
+232,634
| +2% | +$12.9M |
|
|
FFEU
33
DELISTED
Barclays ETN+ FI Enhanced Europe 50 ETN Series C
FFEU
| $617M | 0.84% |
8,324,140
+701,536
| +9% | +$57.8M |
|
34
UBS Group
UBS
$170B
| $604M | 0.83% |
48,827,266
+773,209
| +2% | +$10.5M |
|
35
AstraZeneca
AZN
$263B
| $568M | 0.78% |
7,482,620
+724,258
| +11% | +$56.6M |
|
36
Costco
COST
$411B
| $567M | 0.77% |
2,783,103
+102,384
| +4% | +$22.9M |
|
37
Petrobras
PBR
$115B
| $546M | 0.75% |
41,992,260
+1,403,304
| +3% | +$20.3M |
|
38
iShares MBS ETF
MBB
$39.1B
| $541M | 0.74% |
5,172,101
+214,734
| +4% | +$22.1M |
|
39
GSK
GSK
$105B
| $539M | 0.74% |
11,282,048
+72,986
| +0.7% | +$3.59M |
|
40
JPMorgan Chase
JPM
$896B
| $530M | 0.72% |
5,426,978
+208,780
| +4% | +$22.2M |
|
41
Chevron
CVX
$363B
| $517M | 0.71% |
4,755,742
+143,056
| +3% | +$16.6M |
|
42
Vale
VALE
$60.4B
| $495M | 0.68% |
37,531,858
+3,410,652
| +10% | +$48.7M |
|
43
ING
ING
$92.4B
| $472M | 0.64% |
44,291,190
+345,276
| +0.8% | +$4.15M |
|
|
44
Salesforce
CRM
$140B
| $468M | 0.64% |
3,416,140
+2,188,122
| +178% | +$301M |
|
45
RTX Corp
RTX
$264B
| $462M | 0.63% |
6,898,172
+233,491
| +4% | +$18.3M |
|
46
Rio Tinto
RIO
$146B
| $460M | 0.63% |
9,487,110
+211,584
| +2% | +$10.3M |
|
47
HDFC Bank
HDB
$136B
| $458M | 0.63% |
17,691,948
+119,476
| +0.7% | +$2.82M |
|
48
Eli Lilly
LLY
$1.05T
| $444M | 0.61% |
3,834,527
+107,857
| +3% | +$12M |
|
49
Banco Santander
SAN
$196B
| $440M | 0.6% |
102,466,515
+3,404,818
| +3% | +$15.4M |
|
50
AB InBev
BUD
$153B
| $416M | 0.57% |
6,322,922
-123,657
| -2% | -$9.46M |
|
Similar funds
